How Bayer and Takeda Pharmaceuticals Use IP eLearning To Prevent Common IP Risks and Missed IP Opportunities

Preventing Common IP Risks with eLearning

In today’s fast-paced business world, the demand for expedited product and service launches that outperform the competition in terms of quality, speed, and affordability is higher than ever. This presents a myriad of distinct IP challenges for businesses.

Rewatch our webinar to explore innovative approaches in utilizing eLearning to address the complexities associated with your IP strategy. Gain valuable insights from Executive IP's Raymond Guarnieri, joined by industry experts Henning Luetjens, Head of Patents at Bayer Intellectual Property GmbH, and Mario Cloutier, Senior Patent Agent at Takeda Pharmaceuticals. You will discover how they effectively employ Executive IP to confront and overcome IP challenges in their respective domains.

Discover more best practices in corporate IP education by downloading our eBook.